Patents Examined by Pamela M Bays
  • Patent number: 11583691
    Abstract: A method of stimulation treatment for medical disorders using stimulation parameters that provide stimulation of a target site directly or create partial stimulation signals that combine into vector signals that stimulate a target site. Stimulation signals have characteristics such as frequency, timing, temporal content that is adjusted for the person being treated. Signals are designed with advantageous characteristics to influence target tissue in an intended manner and avoid producing unwanted side-effects. Stimulation signals are designed to match or avoid internal/endogenous activity (e.g., brain patterns and rhythms) of a patient. Methods for choosing, creating and partial signals are provided. Tissue modulation may be accomplished with electrical and/or magnetic stimulation, such as repetitive transcranial magnetic stimulation.
    Type: Grant
    Filed: May 3, 2021
    Date of Patent: February 21, 2023
    Inventor: Michael Sasha John
  • Patent number: 11554260
    Abstract: A method of responding to an adverse event associated with an implantable blood pump including detecting the adverse event, reducing a pump speed of the blood pump relative to a set pump speed in response to the detected adverse event, and determining whether at least one of a group consisting of the adverse event and a second adverse event is present following the reducing of the pump speed of the blood pump. If the at least one of the group consisting of the adverse event and a second adverse event is not present, the method includes increasing the pump speed to the set pump speed and if the at least one of the group consisting of the adverse event and a second adverse event is present while increasing the pump speed to the set pump speed, the method includes reducing the pump speed to a maximum safe operating speed.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: January 17, 2023
    Assignee: HeartWare, Inc.
    Inventors: Carlos Reyes, Katherine Chorpenning, Antonio Luiz Silva Ferreira, Neethu Lekshmi Vasudevan Jalaja, Justin Wolman, Fernando Casas
  • Patent number: 11534229
    Abstract: A system and method of controlling the application of energy to tissue using measurements of impedance are described. The impedance, correlated to the temperature, may be set at a desired level, such as a percentage of initial impedance. The set impedance may be a function of the initial impedance, the size and spacing of the electrodes, the size of a targeted passageway, and so on. The set impedance may then be entered into a PID algorithm or other control loop algorithm in order to extract a power to be applied to a treatment device.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: December 27, 2022
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Jerry Jarrard
  • Patent number: 11458299
    Abstract: A lead body for implantation includes a first set of conducting sections, a second set of conducting sections, a strain relief coupler having a axial length with a plurality of tines extending along the axial length and extending radially thereby defining a plurality of axially-extending channels, a plurality of joints located within the plurality of channels, each joint coupling one conducting section from the first set of conducting sections to one conducting section from the second set of conducting sections, and an outer layer at least partially surrounding the first and second set of conducting sections, the plurality of joints and the strain relief coupler.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: October 4, 2022
    Assignee: Heraeus Medical Components LLC
    Inventors: Robert R. Cass, Paul Noffke, Alan Carlson
  • Patent number: 11433239
    Abstract: An active implantable medical device includes a VNS pulse bursts generator for stimulation of the vagus nerve according to several selectable configurations. The device may further include a sensor of the current activity level of the patient. The generator is controlled on the activity signal via a classifier determining the class of the current level of activity among a plurality of classes of activity. A controller selects a configuration of VNS therapy depending on the class of activity thus determined. Limits of the activity classes are dynamically changeable by a calibration module that conducts a historical analysis of the successive current activity levels over a predetermined analysis period. The calibration module can prepare a histogram of the historical analysis, and can define the limits of the activity classes depending on the outcome of the historical analysis and the histogram.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: September 6, 2022
    Assignee: Sorin CRM SAS
    Inventor: Jean-Luc Bonnet
  • Patent number: 11426136
    Abstract: According to one embodiment, an X-ray diagnostic system is used with an operation apparatus for operating, from a position separated from an object, a device inserted inside the object, and includes an imaging apparatus, an designation receiving circuit, a first display, and a second display. The imaging apparatus performs X-ray imaging of the object. The designation receiving circuit receives designation of a position on medical data from a first user who operates the device. The first display is disposed at a position visible from the first user, and displays a first image according to the designation of the position. The second display is disposed at a position visible from a second user who performs positioning of the imaging apparatus, and displays a second image different from the first image according to the designation of the position.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: August 30, 2022
    Assignee: Canon Medical Systems Corporation
    Inventors: Masaki Akiyama, Yoshimasa Kobayashi, Jun Sakakibara, Keisuke Nakamura, Satoru Ohishi
  • Patent number: 11413451
    Abstract: Devices, systems and methods for reducing migration of leads, catheters and similar devices are provided. In particular, devices, systems and methods are provided for creating a slack anchor which assists in maintaining the lead or catheter in a desired position. In some embodiments, the slack anchor is created within the epidural space. When targeting nerve anatomy within the spinal column or in the vicinity of the epidural space, anchoring within the epidural space allows the associated lead or catheter to be anchored as close to the target therapy site as desired or possible. By anchoring close to the target therapy site, the risk of movement or migration is significantly reduced or eliminated.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: August 16, 2022
    Assignee: St. Jude Medical Luxembourg Holdings SMI S.A.R.L. (“SJM LUX SMI”)
    Inventors: Eric J. Grigsby, Daniel M. Brounstein, Fred I Linker
  • Patent number: 11413468
    Abstract: Signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, detected events are analyzed to identify changes in detected event amplitudes. When detected event amplitudes are dissimilar from one another, a first set of detection parameters may be invoked, and, when detected event amplitudes are similar to one another, a second set of detection parameters may be invoked. Additional examples determine whether the calculated heart rate is “high” or “low,” and then may select a third set of detection parameters for use when the calculated heart rate is high.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: August 16, 2022
    Assignee: CAMERON HEALTH, INC.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren
  • Patent number: 11406845
    Abstract: Disclosed are systems and methods for the treatment of cardiac arrhythmias.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: August 9, 2022
    Assignee: Washington University
    Inventors: Clifford G. Robinson, Phillip S. Cuculich
  • Patent number: 11389661
    Abstract: The present invention involves methods and systems for treatment of brain disorders using neuromodulation of brain networks. Implantation occurs by selecting sites which modulate the network in selected manners, or are modulated by a stimulus in a particular manner that is relevant to treatment of the network. The candidate locations within a brain region are evaluated in relation to how these are indirectly modulated by stimulation at a different brain region. Treatment of one or more brain networks associated with a brain disorder is realized with a consideration of network dynamics and coupling effects such as indirect stimulation of non-target regions. A brain modulation system (BMS) increases, decreases, or otherwise modulates network regional activity in a differential manner. Therapy and electrode locations are adjusted using sensed data and target implantation criteria related to the brain network model.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: July 19, 2022
    Inventor: Michael Sasha John
  • Patent number: 11383076
    Abstract: Disclosed are techniques to generate ideal or near ideal profiles for regulation of the volume of fluid flow in a drive system of a pump for an externally mechanically supported heart, pressure in or near the pump, or measured strain/strain rates of the supported heart, based on an estimate/measurement of the heart's size. A part of the techniques for regulation may focus on achieving mechanical synchrony with the intrinsic cyclic pump function of a partially functional heart. The techniques do not fundamentally rely on hemodynamic measurements to function. However, when hemodynamic measures are available, those measures can be fed to control algorithms to increase the efficacy of regulation to restore the heart's pump function.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: July 12, 2022
    Assignee: LifeBridge Technologies, LLC
    Inventor: Mark P. Anstadt
  • Patent number: 11357437
    Abstract: Apparatus, consisting of a catheter that is configured to be inserted into a chamber of a heart and that has one or more electrodes configured to contact myocardial tissue at multiple locations in the chamber. The one or more electrodes receive electrical signals responsive to a conduction wave traveling through the tissue. The apparatus includes a display and a processor that is configured to receive the electrical signals from the catheter and to render to the display, responsively to the electrical signals, a map of the chamber including an indication of local times of occurrence of the conduction wave at the multiple locations. The processor is also configured to calculate, responsively to the local times of occurrence, a velocity of the conduction wave between the locations and to mark on the map one or more areas of the chamber in which the velocity is below a preset threshold.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: June 14, 2022
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Natan Sharon Katz, Benjamin Cohen, Lior Zar, Vincent Alexandre Roger
  • Patent number: 11351361
    Abstract: A system and method are provided for a wireless electrical stimulation. The system generally includes at least two electrical stimulation units. Each electrical stimulation unit includes electrodes connected to the unit. The system also includes a transmitter for remotely, wirelessly controlling each of the electrical stimulation units to selectively apply a time-varying electric potential to the electrodes to provide an electrical stimulation to tissue in electrical contact with the electrodes.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: June 7, 2022
    Assignee: HI-DOW IPHC, INC.
    Inventor: Eric Ye Chen
  • Patent number: 11338140
    Abstract: Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers. One aspect includes a comparison of baseline and post-modulation levels of one or more biomarkers in bodily fluid that have each been collected from a human subject at a relevant time, and that may be used to assess the neuromodulation efficacy. The post-neuromodulation levels for the one or more biomarkers may be collected from the human subject within about 5 minutes to about 14 days post-neuromodulation.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: May 24, 2022
    Inventors: Ayala Hezi-Yamit, Rudy Beasley, Susan Edwards, Lori Garcia, Michele Lee Silver, Christopher W. Storment, Carol M. Sullivan, Joseph A. Traina, Stefan Stoyanov Tunev
  • Patent number: 11331489
    Abstract: In some examples, a medical device is configured to deliver high dose electrical stimulation therapy to a patient by at least generating and delivering an electrical stimulation signal having a relatively high duty cycle, and a stimulation intensity less than a perception or paresthesia threshold intensity level for the patient. The pulses of the electrical stimulation signal may each have a relatively low amplitude, but due at least in part to a relatively high number of pulses per unit of time, a dose of the electrical stimulation may be high enough to elicit a therapeutic response from the patient.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: May 17, 2022
    Assignee: MEDTRONIC, INC.
    Inventor: Lisa M. Johanek
  • Patent number: 11331492
    Abstract: Methods and apparatus are disclosed relating to the stimulating of tissue including nerve tissue based on combinations of capacitors and resistors. Application and removal of voltage to an electrical circuit is taught as part of a method of creating voltage waveforms for nerve and other tissue with such waveforms creating neural signals. The electrical apparatus taught may, include a first electrical node grounded through a first resistor; a second electrical node grounded through a second resistor; a first capacitor connected to both the first electrical node and the second electrical node; a second capacitor separating the second electrical node from a biological grounding point and direct current sources connected to the two nodes.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: May 17, 2022
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jose A. Parodi Amaya, Edward F Austin, Jin-Woo Choi
  • Patent number: 11311344
    Abstract: A surgical device for operating on tissue comprises an end effector, a shaft, and an interface assembly. The shaft comprises an articulation section operable to provide deflection of the end effector relative to the longitudinal axis of the shaft. The interface assembly comprises a plurality of pulleys associated with drive shafts driven by an external system. The pulleys are operable to cause rotation of one or both of the shaft or end effector. The pulleys are further operable to cause articulation of the articulation section. The interface assembly further comprises drive components operable to cause movement of components of the end effector.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: April 26, 2022
    Assignee: Cilag GmbH International
    Inventor: Shailendra K. Parihar
  • Patent number: 11311719
    Abstract: Stimulation lead includes an elongated lead body having distal and proximal ends and wire conductors extending therebetween. The stimulation lead also includes a lead paddle having a multi-dimensional array of electrodes positioned along a contact side of the lead paddle. The electrodes are electrically coupled to the wire conductors. The lead paddle includes a paddle body and a conductor organizer disposed within the paddle body. The conductor organizer has multiple channels extending along the lead paddle. The channels receive the wire conductors and retain the wire conductors in a designated arrangement with respect to the lead paddle. The conductor organizer has openings to the channels. The wire conductors extend through the openings and are terminated to the respective electrodes.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: April 26, 2022
    Inventors: Jodi T. Dubuclet, Cory Brinkman
  • Patent number: 11305114
    Abstract: A system for treating disordered breathing of a human being includes an implantable transvenous stimulation lead having at least one stimulation electrode and a sensor configured to detect activity level of the human being. The system includes an energy source, a pulse generator and circuitry, the circuitry operative to receive a signal indicative of the activity level of the human being from the sensor, wherein the circuitry is configured to cause the energy source and the pulse generator to deliver spaced apart stimulation signals to the at least one stimulation electrode while the activity level of the human being is sufficiently low to be indicative of sleep. Spaced apart stimulation pulses from the electrode are configured to extend a duration of a time of at least one breath being defined as the time from an onset of inhalation to the onset of inhalation of a successive breath.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: April 19, 2022
    Inventors: Mark Gelfand, Howard Levin, Andrew Halpert, Antonis Panteleon
  • Patent number: 11305119
    Abstract: An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: April 19, 2022
    Inventors: Mark Gelfand, Howard R. Levin, Andrew Halpert